Professor Nick Turner discusses the latest results from a phase III clinical trial (Paloma-3) of the drug the findings strengthen the case for making palbociclib available to women whose cancer has progressed on prior hormone therapy.
Here in London, our scientists conduct world-leading research every day. Our mission? To defeat cancer.
During Childhood Cancer Awareness Month, Professor Chris Jones speaks about how his team's research into childhood cancer, wouldn't be possible without the generous support from donors and partners.
Tina tells us about what it meant to her to share her story with the ICR.
ICR fundraiser Adam Lee reflects on his incredible challenge of running 12 ultramarathons in 7 months for the ICR.
Professor Mel Greaves talks about how a major new analysis has revealed for the first time the likely cause of most cases of childhood leukaemia and that the disease may be preventable.
Patient advocate Cara Hoofe describes her experiences of being out of active treatment following treatment for colorectal cancer.
Tina Manning talks about her experience of being diagnosed with malignant melanoma and treated with pembrolizumab.
Dr Sebastian Guettler talks us through the new chromatography machine, purchased using generous donations from ICR supporters.